Macquarie Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.49M | Hold |
69,169
| – | – | ﹤0.01% | 1161 |
|
|
2025
Q1 | $2.15M | Buy |
69,169
+23,021
| +50% | +$717K | ﹤0.01% | 1194 |
|
|
2024
Q4 | $1.18M | Sell |
46,148
-640
| -1% | -$16.3K | ﹤0.01% | 1321 |
|
|
2024
Q3 | $1.32M | Hold |
46,788
| – | – | ﹤0.01% | 1326 |
|
|
2024
Q2 | $1.23M | Buy |
46,788
+1,062
| +2% | +$28K | ﹤0.01% | 1337 |
|
|
2024
Q1 | $1.39M | Hold |
45,726
| – | – | ﹤0.01% | 1314 |
|
|
2023
Q4 | $1.28M | Buy |
45,726
+9,217
| +25% | +$259K | ﹤0.01% | 1324 |
|
|
2023
Q3 | $991K | Buy |
36,509
+18,304
| +101% | +$497K | ﹤0.01% | 1340 |
|
|
2023
Q2 | $560K | Buy |
18,205
+8,982
| +97% | +$276K | ﹤0.01% | 1442 |
|
|
2023
Q1 | $332K | Hold |
9,223
| – | – | ﹤0.01% | 1504 |
|
|
2022
Q4 | $364K | Buy |
9,223
+2,145
| +30% | +$84.8K | ﹤0.01% | 1550 |
|
|
2022
Q3 | $285K | Buy |
7,078
+2,447
| +53% | +$98.5K | ﹤0.01% | 1581 |
|
|
2022
Q2 | $195K | Hold |
4,631
| – | – | ﹤0.01% | 1719 |
|
|
2022
Q1 | $180 | Buy |
4,631
+1,930
| +71% | +$75 | ﹤0.01% | 1818 |
|
|
2021
Q4 | $107K | Sell |
2,701
-2,380
| -47% | -$94.3K | ﹤0.01% | 1922 |
|
|
2021
Q3 | $184K | Hold |
5,081
| – | – | ﹤0.01% | 1816 |
|
|
2021
Q2 | $209K | Buy |
5,081
+137
| +3% | +$5.64K | ﹤0.01% | 1797 |
|
|
2021
Q1 | $216K | Buy |
4,944
+2,944
| +147% | +$129K | ﹤0.01% | 1686 |
|
|
2020
Q4 | $100K | Buy |
+2,000
| New | +$100K | ﹤0.01% | 1874 |
|